Mesa Laboratories Balance Sheet
NASDAQ: MLABIndustrialsIndustrial Machinery/ComponentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Mesa Laboratories financial position
At the end of fiscal 2026, Mesa Laboratories reported total assets of $427.7 million, down 1.3% from a year earlier against total liabilities of $241.5 million. Shareholders' equity stood at $186.2 million, or 43.5% of assets. The company held $26.9 million in cash and equivalents against $67.5 million of debt, a net debt position of $40.6 million.
The current ratio (current assets divided by current liabilities) was 1.72, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.36.
Summary generated from market data by MetaCap's automated system. Methodology
Mesa Laboratories balance sheet (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 | FY 20172017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 26.93M | 27.32M | 28.21M | 32.91M | 49.35M | 263.87M | 81.38M | 10.19M | 5.47M | 5.82M |
| Receivables | 44.10M | 41.97M | 39.05M | 42.55M | 41.22M | 23.79M | 21.13M | 12.52M | 14.30M | 14.32M |
| Inventory | 26.37M | 25.36M | 32.67M | 34.64M | 24.61M | 11.18M | 11.18M | 6.77M | 9.23M | 13.87M |
| Total Current Assets | 106.27M | 102.69M | 109.35M | 118.97M | 124.32M | 303.75M | 122.79M | 33.62M | 31.99M | 35.78M |
| Property, Plant & Equipment | 30.61M | 32.33M | 31.77M | 28.15M | 28.62M | 22.00M | 22.07M | 22.23M | 23.59M | 26.00M |
| Goodwill | 186.86M | 181.76M | 180.10M | 286.44M | 291.17M | 160.84M | 141.54M | 66.38M | 65.54M | 72.16M |
| Intangible Assets | 83.35M | 96.88M | 113.75M | 216.81M | 250.12M | 111.74M | 119.87M | 33.22M | 42.85M | 37.79M |
| Total Assets | 427.75M | 433.35M | 446.80M | 661.83M | 707.37M | 601.48M | 409.11M | 156.77M | 164.10M | 171.73M |
| Accounts Payable | 4.93M | 5.75M | 6.04M | 6.13M | 7.90M | 4.47M | 3.41M | 2.90M | 2.38M | 2.17M |
| Short-Term Debt | — | — | — | — | — | — | — | 2.13M | 1.63M | 1.13M |
| Total Current Liabilities | 61.90M | 163.96M | 44.31M | 43.36M | 48.05M | 32.58M | 26.01M | 23.66M | 17.29M | 16.57M |
| Long-Term Debt | 67.50M | 71.25M | — | — | — | — | — | 20.61M | 44.63M | 53.67M |
| Total Liabilities | 241.50M | 273.52M | 301.40M | 268.35M | 313.57M | 195.25M | 189.09M | 45.46M | 64.74M | 73.91M |
| Shareholders' Equity | 186.25M | 159.83M | 145.39M | 393.48M | 393.80M | 406.23M | 220.01M | 111.31M | 99.36M | 97.82M |
| Retained Earnings | -185.75M | -188.94M | -183.49M | 74.20M | 76.67M | 72.46M | 72.36M | 73.30M | 68.28M | 73.66M |
| Total Debt | 67.50M | 71.25M | — | — | — | — | — | 22.74M | 46.26M | 54.80M |
| Net Cash (Debt) | -40.57M | -43.93M | 28.21M | 32.91M | 49.35M | 263.87M | 81.38M | -12.55M | -40.79M | -48.98M |
| Shares Outstanding | 5.52M | 5.46M | 5.39M | 5.37M | 5.27M | 5.14M | 4.39M | 3.89M | 3.80M | 3.73M |
This table shows 10 annual periods of Mesa Laboratories's balance sheet, from FY 2026 back to FY 2017, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow MLAB's reporting calendar. What is a balance sheet?